Fast Track Designation follows announcement in January 2024 that the U.S. Food and Drug Administration (FDA) granted a “Study May Proceed” letter for APRINOIA’s planned Phase 3 study of APN-1607 ......
Progress towards Philips Foundation’s 2030 target of 100 million lives improved in underserved communities each year
17 new initiatives with strategic partners and 4 new investments ......
